Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$629M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$482M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$394M |
| 4 |
NVIDIA
NVDA
|
+$306M |
| 5 |
State Street SPDR Bloomberg Convertible Securities ETF
CWB
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$964M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$620M |
| 3 |
Invesco Senior Loan ETF
BKLN
|
+$369M |
| 4 |
Tencent Music
TME
|
+$338M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$304M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 2.5% |
| 2 | Technology | 2.1% |
| 3 | Healthcare | 1.18% |
| 4 | Financials | 0.9% |
| 5 | Industrials | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
CALL
DexCom
DXCM
$31.5B
| $63.7M | 0.02% |
596,800
+379,200
| +174% | +$36.4M |
|
452
Thermo Fisher Scientific
TMO
$213B
| $63.7M | 0.02% |
126,183
-13,337
| -10% | -$6.29M |
|
453
CALL
XPeng
XPEV
$12.4B
| $63M | 0.02% |
1,419,400
-356,400
| -20% | -$12.1M |
|
454
Coca-Cola
KO
$377B
| $62.7M | 0.02% |
1,159,536
+918,970
| +382% | +$50M |
|
455
PUT
Wayfair
W
$11.2B
| $62.2M | 0.02% |
196,900
+24,400
| +14% | +$7.64M |
|
456
CALL
Nucor
NUE
$58.6B
| $62.1M | 0.02% |
647,100
+338,200
| +109% | +$31.6M |
|
457
CALL
Deere & Co
DE
$160B
| $62M | 0.02% |
175,800
-157,800
| -47% | -$57.6M |
|
458
CALL
Warner Bros
WBD
$65.9B
| $61.9M | 0.02% |
2,018,700
+441,300
| +28% | +$15.3M |
|
|
FISV
459
CALL
Fiserv Inc
FISV
$28.8B
| $61.8M | 0.02% |
578,600
-20,400
| -3% | -$2.37M |
|
460
Edwards Lifesciences
EW
$49.6B
| $61.8M | 0.02% |
596,378
+481,653
| +420% | +$45.4M |
|
461
PUT
Starbucks
SBUX
$120B
| $61.5M | 0.02% |
550,200
+118,000
| +27% | +$13.3M |
|
462
CALL
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.72B
| $61.3M | 0.02% |
575,300
+339,500
| +144% | +$33.5M |
|
463
iShares MSCI India ETF
INDA
$6.89B
| $61.3M | 0.02% |
1,385,485
+1,380,039
| +25,340% | +$59.2M |
|
464
CALL
CRISPR Therapeutics
CRSP
$4.73B
| $61.2M | 0.02% |
378,300
-39,900
| -10% | -$4.85M |
|
465
PUT
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $61M | 0.02% |
528,100
+456,500
| +638% | +$52.2M |
|
466
CALL
C.H. Robinson
CHRW
$17.4B
| $60.5M | 0.02% |
645,700
+149,300
| +30% | +$14.6M |
|
467
PUT
Marriott International
MAR
$98.3B
| $60.5M | 0.02% |
442,900
+263,400
| +147% | +$38M |
|
468
First Trust Smith Opportunistic Fixed Income ETF
FIXD
$3.23B
| $60.4M | 0.02% |
1,126,423
+165,228
| +17% | +$8.81M |
|
469
CALL
TAL Education Group
TAL
$6.93B
| $60.4M | 0.02% |
2,394,200
+2,220,600
| +1,279% | +$99.2M |
|
470
CALL
American Express
AXP
$227B
| $60M | 0.02% |
363,200
-319,400
| -47% | -$50M |
|
471
CALL
Datadog
DDOG
$95.4B
| $59.7M | 0.02% |
573,800
+76,300
| +15% | +$6.89M |
|
472
CALL
BlackBerry
BB
$4.98B
| $59.7M | 0.02% |
4,885,800
+2,858,600
| +141% | +$29.9M |
|
473
PUT
Target
TGT
$65.6B
| $59M | 0.02% |
244,100
+26,000
| +12% | +$5.69M |
|
474
PUT
Bunge Global
BG
$20.4B
| $58.4M | 0.02% |
747,000
+717,800
| +2,458% | +$60.6M |
|
475
CALL
Intellia Therapeutics
NTLA
$1.49B
| $58.2M | 0.02% |
359,700
+266,900
| +288% | +$20.8M |
|
Similar funds
Jane Street's Q2 2021 Portfolio in Review
As of Q2 2021, Jane Street held 10,953 positions worth $256B, up 27% from $201B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Jane Street deployed $36.7B of net new capital in Q2 2021, opening 1,924 new positions and adding to 4,221 existing holdings. Its largest new stake was iShares MSCI EAFE ETF: 6,071,963 shares worth $479M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 2.5% of assets, down from 2.8% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Baidu, an estimated $964M trimmed.
- Jane Street's largest Q2 2021 buy was iShares MSCI EAFE ETF: 6,071,963 shares worth $479M.
- Jane Street added most to iShares MBS ETF in Q2 2021, an estimated $629M increase.
- Jane Street's biggest Q2 2021 reduction was Baidu, cutting an estimated $964M.
- Jane Street fully exited Invesco Senior Loan ETF in Q2 2021, selling an estimated $369M.
- Jane Street's ten largest holdings make up 37% of its $256B portfolio in Q2 2021.
- Jane Street opened 1,924 new positions and closed 1,267 in Q2 2021.
- Jane Street's portfolio value rose 27% quarter-over-quarter to $256B.
Based on Jane Street's 13F filing for Q2 2021, filed 16 Aug 2021.